YPEVA
BEVACIZUMAB
Public price
2,91 MAD
Active substance
BEVACIZUMAB
Laboratory
SOTHEMA
What is this medicine?
A vascular endothelial growth factor inhibitor used for the treatment of various types of metastatic and recurrent cancers.
Verified summary
BEVACIZUMAB, SOLUTION A DILUER POUR PERFUSION IV, 100 MG (25 MG / ML), BOITE D'UN FLACON DE 4 ML
Common uses
Metastatic colorectal cancer,Unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer,Recurrent glioblastoma in adults,Metastatic renal cell carcinoma,Persistent, recurrent, or metastatic cervical cancer,Epithelial ovarian, fallopian tube, or primary peritoneal cancer
Class
vascular endothelial growth factor inhibitor
Laboratory
SOTHEMA
Hospital price
2,58 MAD
Strength
100 MG (25 MG / ML)
Form
SOLUTION A DILUER POUR PERFUSION IV
Presentation
BOITE D'UN FLACON DE 4 ML
Commercial status
Commercialisé
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 2,91 MAD
Available presentations and strengths
Medicines with the same active substance
AVASTIN
100 MG / 4 ML · BOITE DE 1 FLACON - AMPOULE DE 4 ML
2,91 MAD
AVASTIN
400 MG / 16 ML · BOITE DE 1 FL-AMPOULE DE 16 ML
9,51 MAD
AVASTIN 100 MG / 4 ML
100 MG / 4 ML · Boîte de 1 flacon-ampoule de 4 ml
2.908,00 MAD
AVASTIN 100 MG / 4 ML
100 MG / 4 ML · Concentré pour préparation d'une solution pour perfusion
2.908,00 MAD
AVASTIN
100 MG · 1 BOITE 1 FLACON
3.983,00 MAD
AVASTIN 400 MG / 16 ML
400 MG / 16 ML · Boîte de 1 flacon-ampoule de 16 ml
9.510,00 MAD
AVASTIN 400 MG / 16 ML
400 MG / 16 ML · Concentré pour préparation d'une solution pour perfusion
9.510,00 MAD
AVASTIN
400 MG · 1 BOITE 1 FLACON
13.417,00 MAD